SEC Filing Summary for DEXCOM INC

Jacob Steven Leach, President, CEO, and Director of DEXCOM INC, reported a transaction on May 22, 2026. He disposed of 1451 shares of Common Stock at a price of $71.90 per share. This transaction resulted in 420,359 shares remaining post-transaction. Additionally, 47,296 shares are held through family holdings, with his spouse as a trustee. The filing also notes that 145,686 unvested restricted stock units are included in the holdings, with various vesting dates through March 8, 2029. A portion of the disposed shares (1451) were withheld by the Issuer to cover tax obligations related to the net settlement of restricted stock units, and do not represent a sale by the Reporting Person.